Privituss

Active substance

L-Cloperastine fendizoate

Strenght and pharmaceutical forms

708 mg/100 ml oral suspension - 100ml bottle
708 mg/100 ml oral suspension - 200ml bottle

ATC

R05DB21 - cough suppressants

Therapeutic Indications

cough suppressants

Marketing Authorization Holder

Aesculapius Farmaceutici S.r.l.

Download area

Summary of Product Characteristics - Privituss – 100ml bottle

Summary of Product Characteristics - Privituss – 200ml bottle